Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Feb;21(2):280-6.
doi: 10.1158/1055-9965.EPI-11-0992-T. Epub 2011 Dec 16.

Use of metformin is not associated with a decreased risk of colorectal cancer: a case-control analysis

Michael Bodmer  1 , Claudia Becker, Christian Meier, Susan S Jick, Christoph R Meier
Affiliations

Use of metformin is not associated with a decreased risk of colorectal cancer: a case-control analysis

Michael Bodmer et al. Cancer Epidemiol Biomarkers Prev. 2012 Feb.

Abstract

Background: To explore the association between use of metformin or other antidiabetic drugs and the risk of colorectal cancer.

Methods: Using the United Kingdom-based General Practice Research Database (GPRD), we conducted a nested case-control analysis in patients with diabetes mellitus. Cases had an incident diagnosis of colorectal cancer, and up to 6 controls per case were matched on age, sex, calendar time, general practice, and number of years of active history in the GPRD prior to the index date. Results were adjusted for multiple potential confounders.

Results: We identified 920 diabetic patients with colorectal cancer. Mean age ± SD was 70.2 ± 8.6 years and 63.3% were male. Extensive use (≥50 prescriptions) of metformin was associated with a slightly increased risk of colorectal cancer (adjusted OR = 1.43, 95% CI: 1.08-1.90) as compared with non use, with an adjustment of OR = 1.81 (95% CI: 1.25-2.62) in men and of 1.00 (95% CI: 0.63-1.58) in women. Neither extensive use of sulfonylureas (adjusted OR = 0.79, 95% CI: 0.60-1.03) nor insulin (adjusted OR = 0.90, 95% CI: 0.63-1.28) were associated with an increased risk of colorectal cancer. A long-term history of diabetes (>10 years) was not associated with a materially increased risk of colorectal cancer compared with short-term diabetes duration (<2 years; adjusted OR = 1.14, 95% CI: 0.90-1.46).

Conclusion: Use of metformin was linked to an increased risk of colorectal cancer in men. Use of sulfonylureas or insulin was not associated with an altered risk of colorectal cancer.

Impact: Metformin does not prevent colorectal cancer.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

Publication types

LinkOut - more resources